14-3-3: A Case Study in PPI Modulation
AbstractIn recent years, targeting the complex network of protein–protein interactions (PPIs) has been identified as a promising drug-discovery approach to develop new therapeutic strategies. 14-3-3 is a family of eukaryotic conserved regulatory proteins which are of high interest as potential targets for pharmacological intervention in human diseases, such as cancer and neurodegenerative and metabolic disorders. This viewpoint is built on the “hub” nature of the 14-3-3 proteins, binding to several hundred identified partners, consequently implicating them in a multitude of different cellular mechanisms. In this review, we provide an overview of the structural and biological features of 14-3-3 and the modulation of 14-3-3 PPIs for discovering small molecular inhibitors and stabilizers of 14-3-3 PPIs. View Full-Text
Share & Cite This Article
Ballone, A.; Centorrino, F.; Ottmann, C. 14-3-3: A Case Study in PPI Modulation. Molecules 2018, 23, 1386.
Ballone A, Centorrino F, Ottmann C. 14-3-3: A Case Study in PPI Modulation. Molecules. 2018; 23(6):1386.Chicago/Turabian Style
Ballone, Alice; Centorrino, Federica; Ottmann, Christian. 2018. "14-3-3: A Case Study in PPI Modulation." Molecules 23, no. 6: 1386.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.